Modifying collagen with alendronate sodium for bone regeneration applications

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Research

Background:

• Phosphorylated materials are promising for bone regeneration by mimicking the bone extracellular matrix (ECM).
• Developing novel phosphorylated biomaterials is crucial for enhancing bone formation and repair.
• Collagen type I is a well-established osteoconductive biomaterial backbone.

Purpose of the Study:

• To design and synthesize a novel phosphorylated collagen type I material (Col-Aln) using alendronate sodium.
• To evaluate the in vitro and in vivo performance of Col-Aln for bone regeneration applications.
• To assess the biocompatibility and osteogenic potential of Col-Aln with bone marrow mesenchymal stem cells (BMSCs).

Main Methods:

• Synthesis of collagen type I phosphorylated with alendronate sodium (Col-Aln).
• In vitro mineralization assays in simulated body fluid.
• Biocompatibility and osteogenic differentiation assays using BMSCs.
• In vivo implantation of Col-Aln scaffolds in critical-sized rat cranial defects for 4 and 8 weeks.
• Histological and micro-CT analysis for new bone formation assessment.

Main Results:

• Col-Aln significantly accelerated in vitro mineralization compared to pure collagen.
• Col-Aln demonstrated excellent biocompatibility, promoting BMSC adhesion and osteogenic differentiation.
• In vivo studies showed that Col-Aln scaffolds degraded appropriately and significantly enhanced new bone formation in rat cranial defects.

Conclusions:

• Col-Aln, a covalently phosphorylated collagen material, is a promising candidate for bone regeneration.
• This study presents a novel strategy for integrating bioactive phosphate molecules into biopolymers.
• Col-Aln effectively promotes mineralization, cell differentiation, and new bone formation, highlighting its therapeutic potential.